|Non-equivalence of Wnt and R-spondin ligands during Lgr5+ intestinal stem-cell self-renewal|
KS Yan, CY Janda, J Chang, GXY Zheng, KA Larkin, VC Luca, LA Chia, ...
Nature 545 (7653), 238-242, 2017
|Expression of specific inflammasome gene modules stratifies older individuals into two extreme clinical and immunological states|
D Furman, J Chang, L Lartigue, CR Bolen, F Haddad, B Gaudilliere, ...
Nature Medicine 23 (2), 174-184, 2017
|Dynamic expression profiling of Type I and Type III Interferon‐stimulated hepatocytes reveals a stable hierarchy of gene expression|
CR Bolen, S Ding, MD Robek, SH Kleinstein
|Quantitative set analysis for gene expression: a method to quantify gene set differential expression including gene-gene correlations|
G Yaari, CR Bolen, J Thakar, SH Kleinstein
Nucleic acids research 41 (18), e170-e170, 2013
|Venetoclax plus rituximab in relapsed chronic lymphocytic leukemia: 4-year results and evaluation of impact of genomic complexity and gene mutations from the MURANO phase III study|
AP Kater, JQ Wu, TJ Kipps, B Eichhorst, P Hillmen, J D’rozario, ...
Journal of Clinical Oncology 38 (34), 2020
|Individual heritable differences result in unique cell lymphocyte receptor repertoires of naïve and antigen-experienced cells|
F Rubelt, CR Bolen, HM McGuire, JA Vander Heiden, D Gadala-Maria, ...
Nature communications 7, 11112, 2016
|Lambda and alpha interferons inhibit hepatitis B virus replication through a common molecular mechanism but with different in vivo activities|
NE Pagliaccetti, EN Chu, CR Bolen, SH Kleinstein, MD Robek
Virology 401 (2), 197-206, 2010
|Dysregulation of B Cell Repertoire Formation in Myasthenia Gravis Patients Revealed through Deep Sequencing|
JA Vander Heiden, P Stathopoulos, JQ Zhou, L Chen, TJ Gilbert, ...
The Journal of Immunology 198 (4), 1460-1473, 2017
|Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL|
M Klanova, LH Sehn, I Bence-Bruckler, F Cavallo, J Jin, M Martelli, ...
Blood 133 (9), 919-926, 2019
|Cell subset prediction for blood genomic studies|
CR Bolen, M Uduman, SH Kleinstein
BMC bioinformatics 12 (1), 258, 2011
|Multicenter Systems Analysis of Human Blood Reveals Immature Neutrophils in Males and During Pregnancy|
J Blazkova, S Gupta, Y Liu, B Gaudilliere, EA Ganio, CR Bolen, ...
The Journal of Immunology 198 (6), 2479-2488, 2017
|Mass cytometry panel optimization through the designed distribution of signal interference|
C Takahashi, A Au‐Yeung, F Fuh, T Ramirez‐Montagut, C Bolen, ...
Cytometry Part A 91 (1), 39-47, 2017
|A randomized, open-label, Phase III study of obinutuzumab or rituximab plus CHOP in patients with previously untreated diffuse large B-Cell lymphoma: final analysis of GOYA|
LH Sehn, M Martelli, M Trněný, W Liu, CR Bolen, A Knapp, D Sahin, ...
Journal of Hematology & Oncology 13, 1-9, 2020
|Mass cytometry identifies a distinct monocyte cytokine signature shared by clinically heterogeneous pediatric SLE patients|
WE O'Gorman, DS Kong, IM Balboni, P Rudra, CR Bolen, D Ghosh, ...
Journal of autoimmunity 81, 74-89, 2017
|PD-L1 and tumor-associated macrophages in de novo DLBCL|
R McCord, CR Bolen, H Koeppen, EE Kadel III, MZ Oestergaard, ...
Blood advances 3 (4), 531-540, 2019
|Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of Atezolizumab|
O Hamid, L Molinero, CR Bolen, JA Sosman, E Muñoz-Couselo, ...
Clinical Cancer Research 25 (20), 6061-6072, 2019
|The Repertoire Dissimilarity Index as a method to compare lymphocyte receptor repertoires|
CR Bolen, F Rubelt, JA Vander Heiden, MM Davis
BMC Bioinformatics 18 (1), 155, 2017
|The Blood Transcriptional Signature of Chronic Hepatitis C Virus Is Consistent with an Ongoing Interferon-Mediated Antiviral Response|
CR Bolen, MD Robek, L Brodsky, V Schulz, JK Lim, MW Taylor, ...
Journal of Interferon & Cytokine Research 33 (1), 15-23, 2013
|Prognostic impact of natural killer cell count in follicular lymphoma and diffuse large B-cell lymphoma patients treated with immunochemotherapy|
M Klanova, MZ Oestergaard, M Trněný, W Hiddemann, R Marcus, ...
Clinical Cancer Research 25 (15), 4634-4643, 2019
|Impaired Toll-Like Receptor 3-Mediated Immune Responses from Macrophages of Patients Chronically Infected with Hepatitis C Virus|
F Qian, CR Bolen, C Jing, X Wang, W Zheng, H Zhao, E Fikrig, RD Bruce, ...
Clinical and Vaccine Immunology 20 (2), 146-155, 2013